Bio-Techne Corp (FRA:TE1)
€ 76.5 1 (1.32%) Market Cap: 11.96 Bil Enterprise Value: 12.28 Bil PE Ratio: 65.48 PB Ratio: 6.45 GF Score: 92/100

Bio-Techne Corp at Morgan Stanley Global Healthcare Conference Transcript

Sep 13, 2022 / 05:30PM GMT
Release Date Price: €84
Valerie Dixon
Morgan Stanley - MD

Hi everybody. We'll get started. Good afternoon. My name is Valerie Dixon. I'm a Managing Director that covers the life sciences tools and diagnostics space in Morgan Stanley's investment banking team. Very excited to host Bio-Techne in our fireside chat this afternoon. We have Jim Hippel, the CFO; and David Clair, the Head of Investor Relations.

But first for important disclosures, please see the Morgan Stanley research disclosure website at morganstanley.com/researchdisclosures. If you have any questions, please reach out to your sales rep.

With that out of the way, we can get started. So Jim, thanks for being here.

James T. Hippel
Bio-Techne Corporation - Executive VP of Finance & CFO

Thanks for having us.

Valerie Dixon
Morgan Stanley - MD

We'd love to give you an opportunity to, if you don't mind, just spend a few minutes to tell folks who aren't familiar with the story. We should be by now, a little bit introduction and your latest thoughts on Bio

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot